HYAX 2,5 MG + 150 UTR POM DERM CT BG AL X 10 G

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1011806250012
  • GGREM 501626070066507
  • Código de barras 7896637030045

O que a fonte publica

Detentor do registro
APSEN FARMACEUTICA S/A
Princípios ativos
VALERATO DE BETAMETASONA;HIALURONIDASE
Embalagem
2,5 MG + 150 UTR POM DERM CT BG AL X 10 G
Tipo de produto
Similar
Classe terapêutica
D7B4 - OUTRAS ASSOCIAÇÕES DE CORTICOSTERÓIDES

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:501626070066507
{
  "name": "HYAX 2,5 MG + 150 UTR POM DERM CT BG AL X 10 G",
  "holder": "APSEN FARMACEUTICA S/A",
  "stripe": null,
  "barcodes": [
    "7896637030045"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "501626070066507",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "62.462.015/0001-29",
  "priceRegime": "Regulado",
  "productName": "HYAX",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "2,5 MG + 150 UTR POM DERM CT BG AL X 10 G",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "46.59",
    "icms-12": "52.94",
    "icms-17": "56.13",
    "icms-18": "56.82",
    "icms-19": "57.52",
    "icms-20": "58.24",
    "icms-21": "58.97",
    "icms-22": "59.73",
    "icms-23": "60.51",
    "icms-17.5": "56.47",
    "icms-19.5": "57.88",
    "icms-20.5": "58.60",
    "icms-22.5": "60.12",
    "icms-12-alc": "47.27",
    "icms-17-alc": "50.12",
    "icms-18-alc": "50.73",
    "icms-19-alc": "51.36",
    "icms-20-alc": "52.00",
    "icms-21-alc": "52.66",
    "icms-22-alc": "53.33",
    "icms-23-alc": "54.02",
    "withoutTaxes": "41.60",
    "icms-17.5-alc": "50.42",
    "icms-19.5-alc": "51.67",
    "icms-20.5-alc": "52.32",
    "icms-22.5-alc": "53.68"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "VALERATO DE BETAMETASONA;HIALURONIDASE",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "62.50",
    "icms-12": "71.02",
    "icms-17": "75.30",
    "icms-18": "76.22",
    "icms-19": "77.16",
    "icms-20": "78.13",
    "icms-21": "79.11",
    "icms-22": "80.13",
    "icms-23": "81.17",
    "icms-17.5": "75.75",
    "icms-19.5": "77.64",
    "icms-20.5": "78.61",
    "icms-22.5": "80.65",
    "icms-12-alc": "65.35",
    "icms-17-alc": "69.29",
    "icms-18-alc": "70.13",
    "icms-19-alc": "71.00",
    "icms-20-alc": "71.89",
    "icms-21-alc": "72.80",
    "icms-22-alc": "73.73",
    "icms-23-alc": "74.68",
    "withoutTaxes": "57.51",
    "icms-17.5-alc": "69.70",
    "icms-19.5-alc": "71.43",
    "icms-20.5-alc": "72.33",
    "icms-22.5-alc": "74.21"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "VALERATO DE BETAMETASONA",
    "HIALURONIDASE"
  ],
  "therapeuticClass": "D7B4 - OUTRAS ASSOCIAÇÕES DE CORTICOSTERÓIDES",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1011806250012",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "D7B4",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:501626070066507"